Literature DB >> 1275701

Carcinoma of the colon and rectum. A review of results of surgical treatment in 164 patients.

D R Miller, F F Allbritten.   

Abstract

This report is a retrospective review of the authors' experience with colonic and rectal carcinoma in 164 patients from 1954 to 1968 with a five-year follow-up. The operative approach utilized principles of early vascular isolation, wied-colon and mesenteric reseciton, and minimal tumor manipulation in curative operations; palliative procedures were aggressively employed. Of the 164 patients, 104 with lesions almost equally divided between colon and rectum had resections with curative intent. The overall five-year survival rate after curative resection was 55%, and included eight hospital deaths that were usually related to cardiopulmonary complications. Lymph node involvement appreciably decreased the survival rate from 72% without node involvement to 39% with node involvement. Patients with rectal lesions experienced more favorable results than those with colonic lesions. Palliative procedures in 46 patients enhanced comfort, but few patients survived longer than one year. Wound and anastomotic complications were infrequent.

Entities:  

Mesh:

Year:  1976        PMID: 1275701     DOI: 10.1001/archsurg.1976.01360240072013

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  3 in total

1.  Patterns of recurrence and survival after laparoscopic and conventional resections for colorectal carcinoma.

Authors:  J E Hartley; B J Mehigan; A W MacDonald; P W Lee; J R Monson
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

2.  Abdominoperineal excision.

Authors:  U Krause; L Påhlman; L Thorén
Journal:  World J Surg       Date:  1982-09       Impact factor: 3.352

3.  Management and survival of carcinoma of the colon: results of a national survey by the American College of Surgeons.

Authors:  J T Evans; J Vana; B L Aronoff; H W Baker; G P Murphy
Journal:  Ann Surg       Date:  1978-12       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.